Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD)

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Gabrielli, Federico ^a   Salvi, Roberto ^b   Garulli, Chiara ^a   Kalogris, Cristina ^a   Arima, Serena ^c   Tardella, Luca ^c   Monaci, Paolo ^a   Pupa, Serenella M ^d   Tagliabue, Elda ^d   Montani, Maura ^a   Quaglino, Elena ^e   Stramucci, Lorenzo ^f   Curcio, Claudia ^f   Marchini, Cristina ^a   Amici, Augusto ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIV LILLE   (France)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITOPE; PERTUZUMAB; TRASTUZUMAB;

ACCURACY; ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE; BREAST CANCER; BREAST METASTASIS; CARCINOMA CELL; CONFORMATION; CONTROLLED STUDY; DNA IMMUNIZATION; EARLY CANCER; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LARGE FRAGMENT PHAGE DISPLAY; MATHEMATICAL ANALYSIS; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PHAGE DISPLAY; PLASMID; PREDICTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REPRODUCIBILITY;

ANIMALS; BALB 3T3 CELLS; BREAST NEOPLASMS; EPITOPES, B-LYMPHOCYTE; FEMALE; HUMANS; MICE; NEOPLASM METASTASIS; PEPTIDE LIBRARY; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTOR, ERBB-2;

RATTUS;

EID: 84875513085     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058358     Document Type: Article

References (24)

1. Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, et al. (2003) Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421: 756-760.
2. Hynes NE, Stern DF, (1994) The biology of erbB-2/neu/HER-2 and its role in cancer. Biochem Biophys Acta Rev Cancer 1198: 165-84.
3. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, et al. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182.
4. Arteaga CL, Sliwkowski MX, Osborne CK, Perez EA, Puglisi F, et al. (2011) Treatment of HER2-positive breast cancer: current status and future perspectives. Nat Rev Clin Oncol 9: 16-32.
5. Disis ML, Calenoff E, McLaughlin G, Murphy AE, Chen W, et al. (1994) Existent T cell and antibody immunity to Her-2/neu protein in patients with breast cancer. Cancer Res 54: 16-20.
6. Peoples GE, Gurney JM, Hueman MT, Woll MM, Ryan GB, et al. (2005) Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients. J Clin Oncol 23: 7536-7545.
7. Amici A, Smorlesi A, Noce G, Santoni G, Cappelletti P, et al. (2000) DNA vaccination with full-length or truncated neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Gene Ther 7: 703-706.
8. Rovero S, Amici A, Di Carlo E, Bei R, Nanni P, et al. (2000) DNA Vaccination against rat Her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice. J Immunol 165: 5133-5142.
9. Curcio C, Di Carlo E, Clynes R, Smyth MJ, Boggio K, et al. (2003) Non redundant roles of antibody, cytokines and perforin in the eradication of established Her-2/neu carcinomas. J Clin Invest 111: 1161-1170.
10. Quaglino E, Iezzi M, Mastini C, Amici A, Pericle F, et al. (2004) Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. Cancer Res 64: 2858-2864.
11. Rolla S, Marchini C, Malinarich S, Quaglino E, Lanzardo S, et al. (2008) Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. Hum Gene Ther 19: 229-239.
12. Quaglino E, Mastini C, Amici A, Marchini C, Iezzi M, et al. (2010) A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding Rat/Human chimeric proteins. Cancer Res 70: 2604-2612.
13. Jacob JB, Quaglino E, Radkevich-Brown O, Jones RF, Piechocki MP, et al. (2010) Combining human and rat sequences in HER-2 DNA vaccines blunts immune tolerance and drives antitumor immunity. Cancer Res 70: 119-128.
14. Gershoni JM, Roitburd-Berman A, Siman-Tov DD, Tarnovitski Freund N, Weiss Y, (2007) Epitope mapping: the first step in developing epitope-based vaccines. BioDrugs 21: 145-156.
15. Yip YL, Smith G, Koch J, Dubel S, Ward RL, (2001) Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design. J Immunol 166: 5271-5278.
16. Jiang B, Liu W, Qu H, Meng L, Song S, et al. (2005) A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2. J Biol Chem 280: 4656-4662.
17. Orlandi R, Formantici C, Menard S, Boyer CM, Wiener JR, et al. (1997) A linear region of a monoclonal antibody conformational epitope mapped on p185HER2 oncoprotein. Biol Chem 378: 1387-1392.
18. Urbanelli S, Bellini R, Carrieri M, Sallicandro P, Celli G, (2000) Population structure of Aedes albopictus (Skuse): the mosquito which is colonizing Mediterranean countries. Heredity (Edinb) 84 (Pt 3): 331-337.
19. Franklin MC, Carey KD, Vajdos FF, Leahy DJ, de Vos AM, et al. (2004) Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 5: 317-328.
20. Lin TM, Halbert SP, Chiu CT, Zarco R, (1981) Simple standardized enzyme-linked immunosorbent assay for human antibodies to Entamoeba histolytica. J Clin Microbiol 13: 646-651.
21. Nagata Y, Furugen R, Hiasa A, Ikeda H, Ohta N, et al. (1997) Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts. J Immunol 159: 1336-1343.
22. Sweredoski MJ, Baldi P, (2008) PEPITO: improved discontinuous B-cell epitope prediction using multiple distance thresholds and half sphere exposure. Bioinformatics 24: 1459-1460.
23. Rolla S, Nicolo C, Malinarich S, Orsini M, Forni G, et al. (2006) Distinct and non-overlapping T cell receptor repertoires expanded by DNA vaccination in wild-type and HER-2 transgenic BALB/c mice. J Immunol 177: 7626-7633.
24. Spadaro M, Ambrosino E, Iezzi M, Di Carlo E, Sacchetti P, et al. (2005) Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (Neoadjuvant Interleukin-12) and adaptive (DNA Vaccine Electroporation) immunity. Clin Cancer Res 11: 1941-1952.